A detailed history of Clear Harbor Asset Management, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 30,800 shares of ROIV stock, worth $385,924. This represents 0.03% of its overall portfolio holdings.

Number of Shares
30,800
Previous 30,800 -0.0%
Holding current value
$385,924
Previous $325,000 9.23%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$10.36 - $11.74 $5,180 - $5,870
500 Added 1.65%
30,800 $325,000
Q1 2024

May 10, 2024

BUY
$9.87 - $11.8 $179,634 - $214,760
18,200 Added 150.41%
30,300 $319,000
Q4 2023

Jan 18, 2024

BUY
$8.38 - $11.58 $101,398 - $140,118
12,100 New
12,100 $135,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.83B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Clear Harbor Asset Management, LLC Portfolio

Follow Clear Harbor Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.